Tabula Rasa HealthCare (TRHC) Aandeel Koers
Tabula Rasa HealthCare Koers
De omzet is de afgelopen 9 jaar met 31,7% per jaar gegroeid tot 299,52 Miljoen USD. De nettowinstmarge van Tabula Rasa HealthCare ligt op -25,8% en is ten opzichte van -23,1% enkele jaren eerder gedaald.
Tabula Rasa HealthCare aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Tabula Rasa HealthCare bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Tabula Rasa HealthCare
Tabula Rasa HealthCare Inc is a healthcare technology company that offers personalized medication safety solutions. Their business model involves developing and deploying technology solutions to enhance patient care and optimize medication management. By leveraging data analytics and proprietary systems, Tabula Rasa provides healthcare organizations with tools to identify and mitigate medication risks, improve patient outcomes, and reduce costs. Through their software platforms, such as MedWise and CareKinesis, Tabula Rasa helps healthcare providers optimize medication regimens and address medication-related challenges. By providing tailored solutions, Tabula Rasa HealthCare Inc aims to enhance medication safety for patients and improve overall healthcare quality.
Tabula Rasa HealthCare Inc is primarily active in the healthcare industry.
The main competitors of Tabula Rasa HealthCare Inc in the market include OptumRx, Cerner Corporation, and McKesson Corporation.
Tabula Rasa HealthCare Inc. is a prominent healthcare technology company with a rich history and background. Founded in 2009, Tabula Rasa HealthCare Inc. specializes in providing innovative solutions for personalized medication management. Through its advanced software platforms and clinical decision support tools, the company aims to improve patient care and reduce healthcare costs. Tabula Rasa HealthCare Inc. offers a wide range of services, including medication risk mitigation, pharmacogenomic testing, and electronic health record integration. With a focus on enhancing patient safety and outcomes, Tabula Rasa HealthCare Inc. has become a trusted name in the healthcare industry, providing cutting-edge solutions for healthcare providers and systems.
Some significant milestones achieved by Tabula Rasa HealthCare Inc include its successful IPO in 2014, being listed on the NASDAQ stock exchange, and consistently delivering strong financial performance. The company has experienced rapid growth and expansion, with acquisitions of Mediture and CareKinesis, further enhancing their offering in personalized medication management services. Tabula Rasa HealthCare Inc has also received several prestigious awards and recognitions, including being named one of the fastest-growing companies by Inc. 5000. These achievements highlight the company's commitment to innovation, strategic acquisitions, and driving positive patient outcomes in the healthcare industry.
Tabula Rasa HealthCare Inc is primarily present in the United States.
Tabula Rasa HealthCare Inc is guided by its core values of integrity, innovation, and collaboration. With a strong corporate philosophy focused on improving healthcare outcomes, Tabula Rasa HealthCare Inc is dedicated to providing personalized medication risk mitigation solutions. The company's mission is to optimize medication regimens for individuals, ensuring safer and more effective healthcare practices. Tabula Rasa HealthCare Inc's commitment to innovation and collaboration helps them drive positive change in the healthcare industry, ultimately benefiting patients and providers. By staying true to its values and corporate philosophy, Tabula Rasa HealthCare Inc aims to revolutionize medication safety and improve patient well-being.
9 analisten beoordelen het aandeel Tabula Rasa HealthCare momenteel: 0 adviseren kopen, 6 houden en 3 verkopen.
Het aandeel Tabula Rasa HealthCare (TRHC) is genoteerd aan 3 beurzen, waaronder: NASDAQ (TRHC), Frankfurt (43T.F), München (43T.MU).
Tabula Rasa HealthCare Inc. (TRHC) is a US company that offers health IT solutions and supports its customers in promoting medication therapy safety. The company provides services in three divisions: Medication Risk Mitigation, Pharmacy Services, and CareVention HealthCare.
De omzet kan momenteel niet worden berekend voor Tabula Rasa HealthCare.
De winst kan momenteel niet worden berekend voor Tabula Rasa HealthCare.
De P/E-ratio kan momenteel niet worden berekend voor Tabula Rasa HealthCare.
De P/S-ratio kan momenteel niet worden berekend voor Tabula Rasa HealthCare.
De Eulerpool Kwaliteitsscore voor Tabula Rasa HealthCare is 5/10.
De ISIN van Tabula Rasa HealthCare is US8733791011. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Tabula Rasa HealthCare is A2ASWL. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Tabula Rasa HealthCare is TRHC. Onder dit beurstickersymbool wordt het Tabula Rasa HealthCare-aandeel op de beurs verhandeld.
Tabula Rasa HealthCare aandeel
Tabula Rasa HealthCare Peer Group
Tabula Rasa HealthCare Ticker
Tabula Rasa HealthCare FIGI
Alle fundamentals en diepgaande analyse van Tabula Rasa HealthCare
Onze aandelenanalyse van het Tabula Rasa HealthCare-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Tabula Rasa HealthCare. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: